Global Sperm Agglutination Market, By Treatment (Assisted Reproductive Technology, Medication), End Use (Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Others) – Industry Trends and Forecast to 2029.
Sperm Agglutination Market Analysis and Size
The market for sperm agglutination is expected to grow during the forecast period. The changing lifestyle and growing obesity, consumption of alcohol, rising awareness about evaluation, tobacco has increased the prevalence of man infertility. This has led to the advancements in the fertilization technologies. Advancement in technology in the field will drive the market for growth.
Data Bridge Market Research analyses that the sperm agglutination market which is expected to reach at a healthy CAGR during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Sperm Agglutination Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Assisted Reproductive Technology, Medication), End Use (Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AB Scientific Ltd. (U.S.), Art Biotech Pvt. Ltd. (India), Cook (U.S.), Dxnow, Inc.(U.S.), Eppendorf SE (U.S.), Esco Micro Pte. Ltd. (Singapore), Hamilton Thorne, Ltd. (U.S.), LabIVF Asia Pte Ltd. (Singapore), Rocket Medical plc (U.K.), The Cooper Companies, Inc.(U.S.), Vitrolife (Europe), Irvine Scientific (U.S.), Microptic (U.S.), The Cooper Companies Inc. (U.S.), Access Pharmaceutical, Inc. (U.S.), Andrology Solutions (U.K.), ASKA Pharmaceuticals Co. Ltd. (Japan), EMD Serono Inc. (U.S.), Intas Pharmaceuticals Ltd. (India)
|
|
Market Opportunities
|
|
Market Definition
Sperm agglutination is the percentage of sperm that is stuck together in the provided sample. Sperm can stick together at the head, tail, or head-to-tail. Sperm aren't supposed to stick together because they can't swim that way. Sperm are supposed to be free-moving, straight-swimming creatures with a healthy shape.
When reading the fertility test results, the percentage assigned to sperm agglutination represents the percentage of sperm stuck together in the sample. For instance, if your sperm sample contained about half of the sperm stuck together, your report would read 50% sperm agglutination.
Global Sperm Agglutination Market Dynamics
Drivers
- Increasing consumption of alcohol
Sperm agglutination is a testing tool for evaluating the strength of a man's sperm to attach with or penetrate egg membrane. The sperm agglutination is rising due to consumption of alcohol and for evaluating the impact of changing lifestyle and growing consumption of fast food, alcohol, tobacco. These are some of the factors which will increase throughout the forecast period due to increased evaluation awareness.
- Advancement in healthcare infrastructure to promote demand
Increased government funding for R&D projects and better healthcare infrastructure will fuel market growth, while technological advancement in the industry will drive market expansion. Additionally, the prevalence of male infertility has increased due to changing lifestyles, rising obesity, increased alcohol and tobacco use, etc., which will further boost market growth.
Opportunities
- Technological developments to promote growth rate
The sperm agglutination market's growth is fuelled by innovation in evaluation in devices with increased efficiency, increased government funding for R&D projects and better healthcare infrastructure will fuel market growth, while technological advancement in the industry will drive market expansion. This will provide beneficial opportunities for the sperm agglutination market growth.
Restraints/Challenges
- Unskilled professionals
The lack of skilled professionals and availability of alternative treatments like sperm agglutination and DNA fragmentation will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the sperm agglutination market.
This sperm agglutination market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sperm agglutination market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sperm Agglutination Market Scope
The sperm agglutination market is segmented on the basis of treatment and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Assisted Reproductive Technology
- Medication
End Use
- Hospitals
- Clinics
- Public Health Labs
- Private or Commercial Labs
- Physician Labs
- Research Institutes
- Others
Sperm agglutination Market Regional Analysis/Insights
The sperm agglutination market is analysed and market size insights and trends are provided by country, treatment and end use as referenced above.
The countries covered in the sperm agglutination market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the sperm agglutination market due to advancement in technology and growing prevalence of men infertility cases will expand market growth in coming years.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to high growth rate in men infertility testing, especially in case of developing economies such as China and India, will fuel market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The sperm agglutination market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sperm agglutination market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sperm agglutination market. The data is available for historic period 2010-2020.
Competitive Landscape and Sperm Agglutination Market Share Analysis
The sperm agglutination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sperm agglutination market.
Some of the major players operating in the sperm agglutination market are:
- AB Scientific Ltd. (U.S.)
- Art Biotech Pvt. Ltd. (India)
- Cook (U.S.)
- Dxnow, Inc. (U.S)
- Eppendorf SE (U.S.)
- Esco Micro Pte. Ltd. (Singapore)
- Hamilton Thorne, Ltd. (U.S.)
- LabIVF Asia Pte Ltd. (Singapore)
- Rocket Medical plc (U.K.)
- The Cooper Companies, Inc. (U.S.)
- Vitrolife (Europe)
- Irvine Scientific (U.S.)
- Microptic (U.S.)
- The Cooper Companies Inc. (U.S.)
- Access Pharmaceutical, Inc. (U.S.)
- Andrology Solutions (U.K.)
- ASKA Pharmaceuticals Co. Ltd. (Japan)
- EMD Serono Inc. (U.S.)
- Intas Pharmaceuticals Ltd. (India)
SKU-